SS

Sachin Srivastava

Active Director Director DIN 06661736
DIN 06661736 First appointment Aug 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2013
Shareholding value •••• Premium profile

About Sachin Srivastava

Data last updated:

Sachin Srivastava is a Director at Abiotic Pharmaceuticals Private Limited (since 2013). The company operates in Trading. Abiotic Pharmaceuticals Private Limited reported revenue of ₹3.9 Lakh (FY 2025).

DIN 06661736
Primary Designation Director
Industry Trading
First Appointment 22 Aug 2013
Oldest Company Age 13 yrs
Largest company Abiotic Pharmaceuticals Private Limited · ₹3.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Aug 20132013₹3.9 Lakh (FY 2025)Active

Board colleagues of Sachin Srivastava

Directorship timeline

Open interactive timeline →
Abiotic Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sachin Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Srivastava

Sachin Srivastava currently holds 1 directorship: Abiotic Pharmaceuticals Private Limited (Director, since 22 Aug 2013, revenue ₹3.9 Lakh (FY 2025)).

Sachin Srivastava was first appointed on 22 Aug 2013 as Director at Abiotic Pharmaceuticals Private Limited.

The current boards of Sachin Srivastava's companies include Chandra Prabha Srivastava (Abiotic Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available